Guided Therapeutics (GTHP) Enterprise Value Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Guided Therapeutics - - 458,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 83.76%
Sep 30, 2025 55.15%
Jun 30, 2025 32.73%
Mar 31, 2025 74.16%
Dec 31, 2024 34.35%
Sep 30, 2024 73.46%
Jun 30, 2024 79.75%
Mar 31, 2024 75.78%
Dec 31, 2023 74.45%
Sep 30, 2023 72.90%
Jun 30, 2023 -204.48%
Mar 31, 2023 -153.38%
Dec 31, 2022 -259.72%
Sep 30, 2022 -398.52%
Jun 30, 2022 51.63%
Mar 31, 2022 41.86%
Dec 31, 2021 -253.30%
Sep 30, 2021 6.88%
Jun 30, 2021 -20.84%
Mar 31, 2021 -5,838.10%
Dec 31, 2020 79.76%
Mar 31, 2020 -250.00%
Mar 31, 2019 92.11%
Sep 30, 2018 5.41%
Jun 30, 2018 -412.50%
Mar 31, 2018 -7,500.00%
Dec 31, 2017 92.86%
Sep 30, 2017 -1,750.00%
Jun 30, 2017 63.64%
Mar 31, 2017 98.21%
Dec 31, 2016 60.00%
Sep 30, 2016 97.67%
Jun 30, 2016 98.89%
Mar 31, 2016 -211.11%
Dec 31, 2015 78.40%
Sep 30, 2015 -309.52%
Jun 30, 2015 -307.01%
Mar 31, 2015 64.00%
Dec 31, 2014 73.57%
Sep 30, 2014 89.50%
Jun 30, 2014 75.51%
Mar 31, 2014 95.49%
Dec 31, 2013 41.34%
Sep 30, 2013 84.03%
Jun 30, 2013 -48.20%
Mar 31, 2013 -23.22%
Dec 31, 2012 50.14%
Sep 30, 2012 -122.07%
Jun 30, 2012 42.98%
Mar 31, 2012 60.99%
Dec 31, 2011 33.75%
Jun 30, 2011 -528.15%